Vaso Completes Sale of NetWolves Network Services
Vaso ( ($VASO) ) has issued an announcement. On July 31, 2026, Vaso Corporation and its subsidiary VasoTechnology, Inc. completed the sale of all issued and outstanding membership interests in
Compare Stocks
Compare up to 40 stocks
Compared Stocks: 1 / 40
Comparison Results
| Name | Sector | Price | Volume | Market Cap | P/E Ratio | Dividend Yield | Analyst Consensus | Analyst Price Target | Smart Score | Leveraged ETF | Article | Follow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 VASO | Healthcare | $0.28 | 235.38K | $50.91M | 17.29 | ― | ― |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| VASO | Vaso | 0.28 | 0.17 | 160.00% |
| Name | Price | % Change | |
|---|---|---|---|
| VASO | $0.28 | +160.00% |
Custom Stock Latest News
Vaso Adds Financial Expert Shaun McMeans to BoardVaso ( ($VASO) ) has provided an update. On July 23, 2026, Vaso Corporation appointed 64-year-old finance executive Shaun McMeans as a Class III director and member of its audit
Vaso shareholders reelect directors and adopt triennial say-on-payVaso ( ($VASO) ) has shared an announcement. At its Annual Meeting of Shareholders held on December 17, 2025, Vaso Corporation’s shareholders elected three Class II directors—Behnam Movaseghi, Jane Moen,
Vaso announces fifth extension of sales agreement with GE HealthCareVaso Corporation (VASO) announced that its wholly owned subsidiary, Vaso Diagnostics, Inc. d/b/a VasoHealthcare, has signed an amendment to the sales representation agreement with GE HealthCare (GEHC) to extend the
Vaso Sells Subsidiary VasoHealthcare IT to Nano-XVaso ( ($VASO) ) has shared an update. On November 19, 2025, Vaso Corporation announced its agreement to sell its subsidiary, VasoHealthcare IT Corp, to Nano-X Imaging Ltd. This decision
Vaso Corporation to sell VasoHealthcare IT to Nano-X ImagingVaso Corporation (VASO) hasreached an agreement, subject to certain conditions, with Nano-X Imaging (NNOX) to sell one of its subsidiaries, VasoHealthcare IT Corp. The parties intend to complete the sale
Vaso Corporation reports Q3 revenue $22.7M vs. $20.8M last year“For the third quarter of 2025, the Company’s total revenue was $22.7 million, an increase of $1.9 million, or 9.1%, from prior year’s third quarter revenue of $20.8 million. All
12M agoVASO
Vaso Corporation reports Q2 revenue $20M vs. $20.2M last year“The Company’s 2025 second quarter revenue was $20.0 million, slightly down from $20.2 million for the same quarter of the prior year,” commented Dr. Jun Ma, President and Chief Executive
1y agoVASO
Vasomedical reports Q4 revenue $27M vs. $21.9M last year“Continuing the trend of top-line growth, the Company’s annual revenue reached another record of $86.8 million for the fiscal year 2024, an increase of $5.7 million or 7% when compared
1y agoVASO
Vaso Announces Major Management Changes for 2025The latest update is out from Vaso ( ($VASO) ). Vaso announced significant management changes effective January 1, 2025. Jane Moen has been appointed as the Chief Operating Officer, while
Most Recent Earnings of Custom Stocks
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| VASO | Nov 16, 2026TBA | $50.91M | ― | ― | 0.30 | 17.29 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
- Comprehensive Analysis: Compare up to 40 stocks with detailed metrics including price, market cap, P/E ratio, dividend yield, and more.
- Analyst Ratings: View consensus ratings from top Wall Street analysts and their price targets for each stock.
- Performance Tracking: Analyze historical performance with interactive charts showing 3-month, 6-month, 1-year, YTD, 3-year, and 5-year returns.
- Dividend Information: Evaluate dividend yield, payout ratio, and dividend growth for income-focused investors.
- Earnings Data: Compare earnings per share (EPS), revenue growth, and profitability metrics across companies.
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.
All Stock Comparison Categories
Custom Stock - FAQ
Which Custom stocks have a "Strong Buy" analyst rating?
None of the selected stocks have a “Strong Buy” analyst rating consensus.
Are Custom stocks overpriced?
Vaso's stock price is currently $0.28, and its average 12-month price target is N/A.
Which Custom stocks pay dividends?
Vaso does not currently pay dividends.